Keros Therapeutics Major Holder ADAR1 Sells $115K in Stock, Exercises Put Options
ADAR1 Capital Management LLC and related entities reported significant trading activity in Keros Therapeutics (KROS) securities on June 20, 2025.
Rhea-AI Filing Summary
ADAR1 Capital Management LLC and related entities reported significant trading activity in Keros Therapeutics (KROS) securities on June 20, 2025. The transactions involved both direct stock sales and put option exercises:
- ADAR1 Partners LP disposed of 1,500 shares of common stock: - 100 shares at $60 per share - 1,400 shares at $70 per share
- Spearhead Insurance Solutions IDF LLC disposed of 200 shares at $70 per share
- Related put options were exercised, corresponding to the stock dispositions: - One $60 strike put option for 100 shares - Sixteen $70 strike put options for 1,600 shares total
Following these transactions, ADAR1 Partners LP maintains beneficial ownership of 4,391,237 shares, while Spearhead Insurance Solutions holds 743,358 shares. All reporting persons are considered 10% owners of Keros Therapeutics, with Daniel Schneeberger serving as the manager of the related entities.
Positive
- None.
Negative
- 10% owner ADAR1 Capital Management disposed of a total of 1,700 shares through put option exercises at $60-70 per share, reducing their significant holdings
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| In-the-Money Exercise | Put Option (right to sell) | 1 | $0.00 | $0.00 |
| In-the-Money Exercise | Put Option (right to sell) | 14 | $0.00 | $0.00 |
| In-the-Money Exercise | Put Option (right to sell) | 2 | $0.00 | $0.00 |
| In-the-Money Exercise | Common Stock | 100 | $60.00 | $6K |
| In-the-Money Exercise | Common Stock | 1,400 | $70.00 | $98K |
| In-the-Money Exercise | Common Stock | 200 | $70.00 | $14K |
Footnotes (2)
- F1. As the investment manager of ADAR1 Partners, LP and as the sub-advisor of Spearhead Insurance Solutions IDF, LLC, ADAR1 Capital Management, LLC may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP and Spearhead Insurance Solutions IDF, LLC. As the general partner of ADAR1 Partners, LP, ADAR1 Capital Management GP, LLC may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP. As the manager of ADAR1 Capital Management, LLC and ADAR1 Capital Management GP, LLC, Mr. Schneeberger may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP and Spearhead Insurance Solutions IDF, LLC.
- F2. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider trading activity occurred at KROS on June 20, 2025?
What put options were exercised in KROS stock by ADAR1 Partners?
Who is Daniel Schneeberger's role in relation to KROS stock ownership?
What is ADAR1 Capital Management's relationship to KROS?
AI-generated analysis. How Rhea-AI works. Not financial advice.